Europe Breast Implants Market Report and Forecast 2024-2032

Europe Breast Implants Market Outlook

The global breast implants market size was valued at USD 2.49 billion in 2023, with Europe holding a significant market share. The market is driven by the increasing prevalence of cancer and the growing demand for aesthetic enhancements. It is expected to grow at a CAGR of 8.4% during the forecast period of 2024-2032, with the values likely to attain USD 5.15 billion by 2032.

Key Takeaways

• Recent data revealed that breast cancer is the most commonly diagnosed cancer for women in the European Union, accounting for 29.4% of cancer cases. The rising burden of breast cancer in the region directly impacts the market demand for breast implants.

• One of the major Europe breast implants market trends is the rise in technological innovation in implant technology such as the advances in 4D printing. For instance, in July 2023, a study reported the development of the first-ever personalized 4D-printed smart implants which can change size according to individual anatomical requirements and also hold the ability to release chemotherapy drugs.

• In September 2023, BellaSeno GmbH, a medical technology manufacturer in Germany, announced positive one-year patient follow-up data for its 3D-printed resorbable breast scaffolds manufactured using additive technologies. The development of such advanced breast implants demonstrating improved outcomes in terms of shape retention and pain management is anticipated to augment the market size.

Europe Breast Implants Market Analysis

Breast implants are medical devices that are used to restore or enhance the breast profile of an individual. They are commonly used in breast augmentation surgery and breast reconstruction surgery. There is a growing demand for aesthetic enhancements supported by decreased stigma associated with cosmetic surgery and a growing emphasis on personal appearance, which significantly contributes to the Europe breast implants market growth.

The market is also driven by the rising burden of breast cancer in the region. Recent data revealed that breast cancer is the most commonly diagnosed cancer for women in the European Union, accounting for 29.4% of cancer cases. Further, the lifetime risk of developing breast cancer was estimated to be 1 in 11 women in the region. Reconstructive surgery is often performed to restore the shape of the breast following a mastectomy. Thus, the increasing prevalence of breast cancer directly impacts the Europe breast implants market demand.

One of the major market trends is the rise in technological innovation in implant technology such as the advances in 4D printing which facilitates the development of smart implants. For instance, in July 2023, a study published in the International Journal of Pharmaceutics reported the development of the first-ever personalized 4D-printed smart implants for breast cancer management by Queen’s University Belfast researchers. These implants can change size according to individual anatomical requirements and also hold the ability to release chemotherapy drugs. Such innovative breast implants are expected to improve breast cancer management and patient satisfaction and are likely to elevate Europe breast implants market value.

The growing emphasis on innovation and customization in breast implants is also influencing the market share, with a visible shift witnessed towards personalized medical devices. In September 2023, BellaSeno GmbH, a medical technology manufacturer in Germany, announced positive one-year patient follow-up data for its 3D-printed resorbable breast scaffolds manufactured using additive technologies. The breast implants exhibited a good safety profile along with a substantial improvement in pain scores reported in breast reconstruction patients with prior silicone implants. The development of such advanced breast implants demonstrating improved outcomes in terms of shape retention and pain management is anticipated to augment market size in the forecast period.

Europe Breast Implants Market Segmentation

The report offers a detailed analysis of the market based on the following segments:

Europe Breast Implants Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Johnson & Johnson Medical Limited

• POLYTECH Health & Aesthetics GmbH

• Sebbin

• GC Aesthetics

• AbbVie Inc.

• ARION LABORATORIES

• Hans Biomed

• Sientra, Inc.

• Establishment Labs Holdings Inc.

• Cereplas

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report

Europe Breast Implants Market Report Snapshots

Europe Breast Implants Market Size

Europe Breast Implants Market Analysis

Europe Breast Implants Companies